Contract Research, Manufacturing & Consulting
Total Trials
3
As Lead Sponsor
2
As Collaborator
1
Total Enrollment
414
NCT02322333
MLD10 in the Prevention of Migraine in Adults
Phase: Phase 2/3
Role: Lead Sponsor
Start: Mar 31, 2015
Completion: Jun 30, 2017
NCT05349981
Lyric Self-replacement Clinical Investigation
Phase: N/A
Role: Collaborator
Start: Jul 29, 2022
Completion: Mar 9, 2023
NCT03567824
MLD10 for the Treatment of Hypomagnesemic Patients With Type 2 Diabetes Mellitus
Phase: Phase 2
Start: Mar 1, 2026
Completion: Apr 30, 2028
Loading map...